Debby Y. Koonen
Groningen, GR 9713GZ, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
L-Citrulline Improves Recovery of Enterocytes While Not Affecting Gut Microbiota in an In Vitro Model of Chemotherapy-Induced Gastrointestinal Mucositis.
Journal: Biomedicines
Published: August 08, 2025
The impact of a humanized bile acid composition on atherosclerosis development in hypercholesterolaemic Cyp2c70 knockout mice.
Journal: Scientific reports
Published: April 09, 2024
Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
Journal: Cardiovascular research
Published: June 30, 2023
Corrigendum to "NF-κB p65 serine 467 phosphorylation sensitizes mice to weight gain and TNFα-or diet-induced inflammation" [Biochim. Biophys. Acta Mol. Cell Res., 1864 (2017): 1785-1798].
Journal: Biochimica et biophysica acta. Molecular cell research
Published: March 15, 2021
Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling.
Journal: Scientific reports
Published: September 17, 2019
Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.
Journal: Circulation research
Published: April 12, 2019
A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis.
Journal: Circulation research
Published: December 25, 2018
Retraction: 5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARγ and PPARα.
Journal: PloS one
Published: July 13, 2018
Pharmacomicrobiomics: a novel route towards personalized medicine?
Journal: Protein & cell
Published: March 05, 2018
5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARγ and PPARα.
Journal: PloS one
Published: April 25, 2017
Last Updated: 09/26/2026